1 Cannabis Stock I’m Buying While It’s Still Cheap

It’s not a popular choice, but it’s hard not to consider Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) right now.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks to really make an impact in the future of my portfolio.

Before I tell you about my cheap stock option, let me be honest. I’m not doing this with retirement around the corner, or even with my children’s education looming. I’m still in my thirties with the time and patience to wait out this and other storms headed my stock’s way. And there are likely to be a few more before it starts riding high again.

But if you’re like me and have the time, patience — and even a little cash to spend, I would put it toward cannabis producer Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB).

Here’s why.

Large — and in charge

Now I know what you’re thinking. Aurora has had major flack over the last year as the company continues to dilute shareholder prices by using that cash to make acquisitions – -and it hasn’t ended there. The company believed it would achieve profitability this year, but has since admitted that likely won’t happen, causing a major share selloff.

Today, the company has very little cash on hand, so investors are hoping the company finally make some sort of partnership to help bring in more funds.

This all sounds quite dire, and I’m not going to lie, things are not going well for Aurora right now. But it’s not alone. Aurora and all other cannabis companies are seeing a huge turning point happen in the industry. It should be expected that many cannabis producers could go bankrupt, and while Aurora has a lot of debt, I don’t think that will happen.

A large part of that is its size. Aurora is the second-largest producer of cannabis in the world, with 625,000 kilograms produced annually and a foothold in 25 countries, including Canada, where it can legally sell marijuana both recreationally and medicinally.

Low costs

Now it’s one thing to be able to produce a lot of pot, but it’s quite another to do it cheap. While the company is still working on paying off its debt of $1.4 billion by cutting costs even further, it’s already well placed among cannabis companies for being able to bring costs down.

While the cannabis producer in Canada produces cannabis at an average of $7.37 per gram, Aurora is light years ahead by doing what it promised and bringing it to below $1. In fact, as of writing that cost is at $0.85 per gram it had reduced the cost of producing cannabis to $0.85 per gram.

The company isn’t stopping there, and frankly it shouldn’t. If it’s not going to be making any partnerships any time soon, costs will have to be cut even further.

The company has announced it will be making some aggressive changes and restructuring to pay down its debt and get investors back on board.

Did I mention cheap?

The main point in all this is that I don’t believe Aurora is going any where, which leaves its share price of $1.21 as of writing at an absurdly cheap price. But don’t get me wrong: I don’t think it’s going to shoot back up to the levels seen back in 2018.

Those days are over for cannabis companies, at least for the next few years while legislation and sales iron out. But the company could easily double its stock price with even a hint of good news.

Granted, I think it will need more than a good earnings report — such as a partnership — but it will happen eventually. And when it does, you’ll be glad you were patient enough to weather the storm.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »